Search research articles
Contact Us
Filters
Showing results (501-510 of 515) with videos related to
Page
of 52
Sort By:
Science Robotics
|
August 13, 2025
Plasticized electrohydraulic robot autopilots in the deep sea
Guorui Li, Peng Shen, Tuck-Whye Wong, et al.
Investigational New Drugs
|
November 15, 2017
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
Xuenong Ouyang, Meiqi Shi, Fangwei Jie, et al.
Journal of Hepatology
|
June 21, 2025
Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD
Sebastian Deschler, Junika Pohl-Topcu, Lukas Ramsauer, et al.
Annals of Translational Medicine
|
April 21, 2020
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial
Zhonghan Zhang, Yunpeng Yang, Ping Lu, et al.
Nature Communications
|
January 12, 2019
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
Gui-Fang Zhu, Yang-Wei Xu, Jian Li, et al.
Imeta
|
August 13, 2024
MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibility
Xin Wei, Li Guo, Hongliu Cai, et al.
BMC Cancer
|
December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study
Xinlong Zheng, Longfeng Zhang, Lin Wu, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis
Qiaofeng Zhong, Longfeng Zhang, Lin Wu, et al.
Gastroenterology
|
August 18, 2020
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
Baoqing Chen, Mihnea P Dragomir, Linda Fabris, et al.
Signal Transduction and Targeted Therapy
|
December 18, 2025
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial
Yongmei Yin, Qingyuan Zhang, Tao Sun, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 515) with videos related to
Sort By:
Page
of 52
Science Robotics
|
August 13, 2025
Plasticized electrohydraulic robot autopilots in the deep sea
Guorui Li, Peng Shen, Tuck-Whye Wong, et al.
Investigational New Drugs
|
November 15, 2017
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
Xuenong Ouyang, Meiqi Shi, Fangwei Jie, et al.
Journal of Hepatology
|
June 21, 2025
Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD
Sebastian Deschler, Junika Pohl-Topcu, Lukas Ramsauer, et al.
Annals of Translational Medicine
|
April 21, 2020
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial
Zhonghan Zhang, Yunpeng Yang, Ping Lu, et al.
Nature Communications
|
January 12, 2019
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
Gui-Fang Zhu, Yang-Wei Xu, Jian Li, et al.
Imeta
|
August 13, 2024
MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibility
Xin Wei, Li Guo, Hongliu Cai, et al.
BMC Cancer
|
December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study
Xinlong Zheng, Longfeng Zhang, Lin Wu, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis
Qiaofeng Zhong, Longfeng Zhang, Lin Wu, et al.
Gastroenterology
|
August 18, 2020
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
Baoqing Chen, Mihnea P Dragomir, Linda Fabris, et al.
Signal Transduction and Targeted Therapy
|
December 18, 2025
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial
Yongmei Yin, Qingyuan Zhang, Tao Sun, et al.
Page
of 52